FUKUDA DENSHI CO.,LTD. (6960) Stock Price

Fukuda Denshi manufactures, procures, and sells medical electronic equipment as its core business, while also providing related logistics and services. The company operates globally through 56 subsidiaries and 1 affiliated company.

Fukuda Denshi's business is organized into four segments: diagnostic equipment, patient monitoring systems, therapeutic devices, and consumables and related products. The diagnostic equipment segment manufactures and sells electrocardiographs and ultrasound diagnostic imaging systems.

The patient monitoring systems segment provides electrocardiogram monitors and vital sign monitors for post-operative critical patients and acute cardiac patients. These systems enable continuous monitoring of patient conditions over extended periods.

The therapeutic devices segment manufactures and sells catheters, defibrillators, pacemakers, and ventilators. The company also provides oxygen therapy and ventilation equipment for home care patients, as well as treatment devices for sleep apnea syndrome.

The consumables and related products segment supplies consumables used in various medical devices, along with repair and maintenance services. The company also manufactures and sells air purification, sterilization, and deodorization systems, addressing the needs of healthcare facilities.

Fukuda Denshi's management philosophy is to contribute to medical advancement through the manufacture and sale of medical devices. The company primarily provides products that improve healthcare quality, focusing on electrocardiographs and respiratory and circulatory system equipment. It pursues differentiated product strategies in response to evolving medical needs, adopting the slogan "Safety, Security, and Comfort" as it aims to become a trusted company.

Despite an uncertain market environment marked by changes in medical reimbursement rates and drug pricing, the company strengthens its quality control and safety management systems. It enhances competitiveness through differentiated product development, improved sales structures, and cost reduction. To improve capital efficiency, the company allocates cash flow to growth investments to increase corporate value.

The medium-term management plan targets efficient organizational operations to address changes in the medical environment accompanying Japan's aging population and declining birthrate. The company strengthens investment and research and development in growth fields, enhancing comprehensive proposals to medical institutions and reinforcing community-based systems in the home healthcare sector. This approach aims to achieve sustainable business operations and increase corporate value.

Fukuda Denshi operates with a mission to support regional healthcare, providing one-stop services spanning prevention through long-term care. Through this approach, the company delivers value to customers and realizes sustained growth. By 2028, the company targets consolidated net sales of 147 billion yen and consolidated operating profit of 28 billion yen, focusing on improved profitability.

The company provides products and services utilizing medical ICT, contributing to operational efficiency for healthcare professionals. Based on its management philosophy, the company creates new value centered on customer-first principles and responds swiftly to changes in the business environment through strengthened collaboration within the group, pursuing further growth.